STADIUM&STREET
Explore S&S

NFL · Medical-care review

NFL and NFLPA review the handling of Jalen Hurts' care

October 25, 2026 · Joint review

Published Sources checked 2 min read
Three distinct public developments: Eagles statement October 15, Eagles and Nicole Lynn medical update October 19, NFL and NFLPA joint review October 25. A chronology is not proof of cause.
Statement dates describe when information became public. They do not establish medical causation.

The NFL and NFL Players Association are jointly reviewing the handling of Jalen Hurts' blood-clot diagnosis. Adam Schefter published their joint statement Sunday, and Associated Press reporting carried by NFL.com confirmed the review.

The announcement confirms a review, not its outcome. It should not be treated as a finding against the Philadelphia Eagles, a ruling that every decision was correct, or evidence that a particular journey caused Hurts' condition.

The team's public chronology

The Eagles' October 15 statement set out their account of the preceding days. It said Hurts sought calf treatment October 8 after reporting that he had been struck by a cleat in the October 4 Rams game. He practiced the following day before the trip to London.

According to that statement, an ultrasound in London found a superficial clot. The team said its medical staff and London doctors reviewed the results and cleared him to play, with follow-up imaging recommended. Hurts played against Jacksonville on October 11. The Eagles said a subsequent ultrasound showed movement in the clot and ruled him out of the Carolina game.

On October 19, the Eagles and agent Nicole Lynn disclosed a diagnosis of deep vein thrombosis and bilateral pulmonary emboli. Their statement described Hurts as clinically stable and said he could not take part in contact activities while receiving blood-thinner treatment. It expressed an expectation of full recovery, without promising a return date.

What the review has not settled

Those statements explain what the team and agent told the public. They are not a substitute for the medical records or the review's eventual conclusions. The sequence alone cannot establish whether an earlier decision caused a later development.

The immediate distinction is straightforward: Hurts' treatment and the examination of how his care was handled are related but separate matters. Neither should become a prediction about his career. A useful review will need to explain its findings clearly; until then, assigning blame or declaring the matter settled would run ahead of the evidence.

Go to the sources

See something that needs attention? Read our corrections process.

All NFL stories ↗